Search research articles
Contact Us
Filters
Showing results (851-860 of 1,038) with videos related to
Page
of 104
Sort By:
Oncotarget
|
June 21, 2019
Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL
John C Byrd, Stephen Smith, Nina Wagner-Johnston, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 20, 2015
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia
James S Blachly, Amy S Ruppert, Weiqiang Zhao, et al.
Pediatrics
|
September 30, 2024
Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings: Clinical Practice Guideline
Scott E Hadland, Rita Agarwal, Sudha R Raman, et al.
Blood
|
April 10, 2025
ZUMA-8: A Phase 1 Study of Brexucabtagene Autoleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Matthew S Davids, Saad S Kenderian, Ian W Flinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity
J C Byrd, T Murphy, R S Howard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2009
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
Y L Kasamon, R J Jones, R A Brodsky, et al.
Blood
|
December 2, 2017
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies
Ian W Flinn, Susan O'Brien, Brad Kahl, et al.
Plos Genetics
|
July 24, 2025
Novel insights into post-myocardial infarction cardiac remodeling through algorithmic detection of cell-type composition shifts
Brian Gural, Logan Kirkland, Abigail Hockett, et al.
Seminars in Oncology
|
February 1, 2017
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
Leo I Gordon, Thomas E Witzig, Greg A Wiseman, et al.
Leukemia
|
June 16, 2012
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
R A Larson, A Hochhaus, T P Hughes, et al.
Page
of 104
Search research articles
Search
Showing results (851-860 of 1,038) with videos related to
Sort By:
Page
of 104
Oncotarget
|
June 21, 2019
Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL
John C Byrd, Stephen Smith, Nina Wagner-Johnston, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 20, 2015
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia
James S Blachly, Amy S Ruppert, Weiqiang Zhao, et al.
Pediatrics
|
September 30, 2024
Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings: Clinical Practice Guideline
Scott E Hadland, Rita Agarwal, Sudha R Raman, et al.
Blood
|
April 10, 2025
ZUMA-8: A Phase 1 Study of Brexucabtagene Autoleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Matthew S Davids, Saad S Kenderian, Ian W Flinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity
J C Byrd, T Murphy, R S Howard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2009
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
Y L Kasamon, R J Jones, R A Brodsky, et al.
Blood
|
December 2, 2017
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies
Ian W Flinn, Susan O'Brien, Brad Kahl, et al.
Plos Genetics
|
July 24, 2025
Novel insights into post-myocardial infarction cardiac remodeling through algorithmic detection of cell-type composition shifts
Brian Gural, Logan Kirkland, Abigail Hockett, et al.
Seminars in Oncology
|
February 1, 2017
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
Leo I Gordon, Thomas E Witzig, Greg A Wiseman, et al.
Leukemia
|
June 16, 2012
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
R A Larson, A Hochhaus, T P Hughes, et al.
Page
of 104